IMGN - ImmunoGen Inc (IMGN) CEO Mark Enyedy on Q3 2019 Results - Earnings Call Transcript
ImmunoGen Inc (IMGN)
Q3 2019 Results Earnings Conference Call
November 1, 2019 8:00 AM ET
Company Participants
Courtney O'Konek - Senior Director of Corporate Communications and Investor Relations
Mark Enyedy - President and Chief Executive Officer
Anna Berkenblit - Senior Vice President and Chief Medical Officer
Conference Call Participants
Boris Peaker - Cowen
Kennen MacKay - RBC Capital Markets
Andy Hsieh - William Blair
Biren Amin - Jefferies
Daniel Wolle - JP Morgan
David Ruch - SVB Leerink
Michael Schmidt - Guggenheim Securities
Joe Catanzaro - Piper Jaffray
Presentation
Operator
Good morning, and welcome to